News
Chronic Lymphocytic Leukemia Therapeutics Market to Grow at 7% CAGR Driven by Targeted Drugs by 2030
The chronic lymphocytic leukemia therapeutics market is expected to grow at a compound annual growth rate of 7% from 2025 to ...
The AI-based clinical trials solution provider is expected to grow at a robust CAGR of approximately 20-25% over the forecast period. Key drivers propelling this growth include the increasing ...
The global gastrointestinal devices market is projected to grow at a CAGR of ~7% during the forecast period. This expansion ...
Global Insulin-Sensitizing Agents Market to Reach USD 22.1 Billion by 2025, Growing at 5% CAGR Through 2032 The global Insulin-Sensitizing Agents Market is poised for steady expansion, projected to ...
Overview of the MarketThe global Medical Robots Market is valued at USD 31.11 billion in 2024 and is projected to reach a ...
Overview of the MarketThe global Prenatal Genetic Testing Market is valued at USD 7.01 billion in 2024 and is projected to ...
Overview of Disposable Syringes MarketThe Disposable Syringes Market is a critical segment of the global healthcare industry, primarily driven by the increasing prevalence of chronic diseases, rising ...
Market OutlineThe Global Weight Loss Drugs Market is valued at USD 2.88 Billion in 2024 and is projected to reach a value ...
Overview of Telepsychiatry MarketThe global Telepsychiatry Market is valued at USD 23.2 Billion in 2024 and is projected to reach a value of USD 146.44 Billion by 2035 at a CAGR (Compound Annual ...
GOTHENBURG, SE / ACCESS Newswire / August 11, 2025 / IRLAB Therapeutics AB (Nasdaq Stockholm:IRLAB A), a company discovering and developing novel treatments for Parkinson's disease, today announces ...
GENEVA, SWITZERLAND / ACCESS Newswire / August 11, 2025 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY ) (Relief, or the Company), a biopharmaceutical company committed to ...
Opinion
TERRY COLE FIX IT! DEA Blocks FDA Cannabis Trials While Contaminated Marijuana Floods State MarketsUp Artist? New DEA Administrator Terrance Cole stands at a crossroads:Break rank, clean house, and restore the DEA's marijuana research credibility by approving MMJ BioPharma's application.Or protect ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results